Results 71 to 80 of about 2,327,860 (219)
Recombinant tissue‐type plasminogen activator treatment in an extremely low birth weight infant
Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth.
Tomonori Kurimoto +3 more
doaj +1 more source
Genetic Susceptibility to Periodontitis
Aim: The aim of this narrative review was to identify genes carrying risk alleles associated with an increased risk of periodontitis and to place them in a biological context. Methods: The literature was reviewed based on predefined criteria. Results: The identified genes largely fall into functions linking immune response with tissue repair. The genes
Gesa M. Richter, Arne S. Schaefer
wiley +1 more source
Background: Stroke has been considered one of the most common life-threatening neurological disease and a global health problem. It causes disability in adults and ranked as the third leading causes of human mortality worldwide.
Zahra Goudarzi +2 more
doaj +1 more source
Prediction of ischemic stroke outcome during thrombolytic therapy
The problem of ischemic stroke in the Russian Federation occupies a leading place in the structure of causes of mortality. Among all treatment methods, the systemic thrombolytic therapy with a recombinant tissue plasminogen activator is regarded as the ...
Yu. D. Minina, V. A. Kalinin
doaj +1 more source
Subconjunctival and topical application of recombinant tissue plasminogen activator in rabbits [PDF]
To quantify fibrin degradation products after topical and subconjunctival administration of recombinant tissue plasminogen activator in rabbits.Fibrin formation was induced in the anterior chamber in 25 rabbits. Subsequently, five rabbits received an injection of r-TPA (positive control) in the anterior chamber, another 10 received a subconjunctival ...
De Abreu Reggi, José Ricardo +4 more
openaire +6 more sources
Periodontitis and metabolic dysfunction‐associated steatotic liver disease
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon +6 more
wiley +1 more source
Hung-Wei Yang,1,* Mu-Yi Hua,1,* Kun-Ju Lin,2,* Shiaw-Pyng Wey,3 Rung-Ywan Tsai,4 Siao-Yun Wu,5 Yi-Ching Lu,5 Hao-Li Liu,6 Tony Wu,7 Yunn-Hwa Ma5 1Chang Gung Molecular Medicine Research Center, Department of Chemical and Materials Engineering, 2Molecular ...
Yang HW +9 more
doaj
Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
Cardiac myxoma is a rare but curable cause of ischemic stroke. Current guidelines do not address the use of intravenous thrombolysis for embolic stroke caused by cardiac myxoma.
Mu-Chien Sun +2 more
doaj +1 more source
An integrated chemical biology and degradomics approach reveals the proteolytic landscape of cathepsin B in mouse macrophages. Z‐RK‐AOMK perturbs the cysteine cathepsin network and reveals that cathepsin B predominantly exhibits dipeptidyl carboxypeptidase activity in cells.
Kai‐Qi Yek +7 more
wiley +1 more source
Tissue plasminogen activator for a left atrial thrombus after Senning repair
To avoid the surgical removal of an obstructive thrombus in a Senning baffle by the administration of recombinant tissue-type plasminogen ...
Rimensberger, Peter +13 more
core +1 more source

